ST
IHE icon

Spinnaker Trust’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Spinnaker Trust’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.37M Hold
15,849
– – 0.08% 132
2025
Q4 		$1.34M Sell
15,849
-2,305
-13% -$184K 0.07% 136
2025
Q3 		$1.32M Hold
18,154
– – 0.07% 132
2025
Q2 		$1.19M Hold
18,154
– – 0.07% 135
2025
Q1 		$1.28M Hold
18,154
– – 0.08% 128
2024
Q4 		$1.19M Hold
18,154
– – 0.08% 128
2024
Q3 		$1.28M Buy
18,154
+1,830
+11% +$128K 0.08% 125
2024
Q2 		$1.08M Sell
16,324
-361
-2% -$23.7K 0.07% 140
2024
Q1 		$1.13M Sell
16,685
-1,108
-6% -$73.2K 0.07% 136
2023
Q4 		$1.1M Sell
17,793
-507
-3% -$29.8K 0.07% 133
2023
Q3 		$1.08M Hold
18,300
– – 0.08% 129
2023
Q2 		$1.09M Sell
18,300
-252
-1% -$15K 0.08% 126
2023
Q1 		$1.08M Sell
18,552
-141
-0.8% -$8.49K 0.08% 122
2022
Q4 		$1.16M Sell
18,693
-387
-2% -$23.3K 0.09% 120
2022
Q3 		$1.08M Hold
19,080
– – 0.09% 121
2022
Q2 		$1.22M Hold
19,080
– – 0.09% 122
2022
Q1 		$1.24M Sell
19,080
-375
-2% -$23.8K 0.08% 128
2021
Q4 		$1.29M Hold
19,455
– – 0.08% 130
2021
Q3 		$1.19M Sell
19,455
-876
-4% -$55.7K 0.08% 128
2021
Q2 		$1.26M Hold
20,331
– – 0.09% 123
2021
Q1 		$1.2M Sell
20,331
-975
-5% -$58.8K 0.09% 119
2020
Q4 		$1.27M Sell
21,306
-1,653
-7% -$94.2K 0.1% 108
2020
Q3 		$1.25M Sell
22,959
-357
-2% -$19.3K 0.11% 104
2020
Q2 		$1.2M Sell
23,316
-8,949
-28% -$450K 0.11% 104
2020
Q1 		$1.45M Sell
32,265
-1,926
-6% -$97.1K 0.16% 96
2019
Q4 		$1.82M Hold
34,191
– – 0.17% 100
2019
Q3 		$1.59M Sell
34,191
-2,016
-6% -$96.5K 0.16% 102
2019
Q2 		$1.82M Sell
36,207
-510
-1% -$25.2K 0.18% 95
2019
Q1 		$1.88M Sell
36,717
-1,797
-5% -$89.4K 0.19% 91
2018
Q4 		$1.81M Sell
38,514
-1,716
-4% -$88K 0.21% 87
2018
Q3 		$2.25M Sell
40,230
-1,212
-3% -$66.2K 0.22% 82
2018
Q2 		$2.09M Sell
41,442
-7,749
-16% -$384K 0.22% 81
2018
Q1 		$2.42M Sell
49,191
-1,326
-3% -$68.1K 0.26% 69
2017
Q4 		$2.6M Sell
50,517
-3,450
-6% -$177K 0.3% 63
2017
Q3 		$2.81M Sell
53,967
-125,208
-70% -$6.43M 0.35% 56
2017
Q2 		$9.27M Buy
179,175
+1,230
+0.7% +$62.2K 1.16% 16
2017
Q1 		$8.95M Buy
177,945
+21
+0% +$1.04K 1.16% 19
2016
Q4 		$8.39M Sell
177,924
-39,879
-18% -$1.89M 1.13% 17
2016
Q3 		$10.8M Buy
217,803
+5,769
+3% +$293K 1.47% 12
2016
Q2 		$10.2M Buy
212,034
+2,808
+1% +$134K 1.41% 15
2016
Q1 		$9.55M Buy
209,226
+4,974
+2% +$233K 1.34% 14
2015
Q4 		$11M Buy
204,252
+12,363
+6% +$650K 1.57% 12
2015
Q3 		$9.47M Buy
191,889
+29,598
+18% +$1.7M 1.45% 14
2015
Q2 		$9.46M Buy
162,291
+2,625
+2% +$153K 1.41% 14
2015
Q1 		$9.18M Buy
159,666
+17,028
+12% +$931K 1.33% 17
2014
Q4 		$7.2M Buy
142,638
+7,938
+6% +$387K 1.07% 22
2014
Q3 		$6.3M Buy
134,700
+1,032
+0.8% +$46.6K 1.02% 25
2014
Q2 		$6.02M Buy
133,668
+1,443
+1% +$62.1K 0.99% 28
2014
Q1 		$5.58M Buy
132,225
+3,717
+3% +$156K 0.92% 30
2013
Q4 		$5.06M Buy
128,508
+1,236
+1% +$46.4K 0.84% 35
2013
Q3 		$4.51M Buy
127,272
+9,003
+8% +$317K 0.82% 38
2013
Q2 		$3.93M Buy
+118,269
New +$3.93M 0.74% 44

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Spinnaker Trust's IHE Position: Q1 2026 in Review

Spinnaker Trust held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 15,849 shares worth $1.37M. The position accounts for 0.08% of the portfolio, ranked #132.

Spinnaker Trust first reported a position in IHE in Q2 2013 and has held it in 52 quarters since. The position peaked at $11M in Q4 2015. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Spinnaker Trust held 15,849 shares of iShares US Pharmaceuticals ETF worth $1.37M as of Q1 2026.
  • Spinnaker Trust left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
  • iShares US Pharmaceuticals ETF made up 0.08% of Spinnaker Trust's portfolio in Q1 2026, its #132 holding.
  • Spinnaker Trust first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
  • Spinnaker Trust's iShares US Pharmaceuticals ETF position peaked at $11M in Q4 2015.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Spinnaker Trust's 13F filing for Q1 2026, filed 23 Apr 2026.